Seroprevalence of Neutralizing Antibodies Against Human Adenovirus Type-5 and Chimpanzee Adenovirus Type-68 in Cancer Patients
Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2018.00335
Full Text
Open PDFAbstract
Available in full text
Date
March 7, 2018
Authors
Publisher
Frontiers Media SA